Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

被引:24
|
作者
Artykov, Artem A. [1 ]
Yagolovich, Anne, V [1 ,2 ]
Dolgikh, Dmitry A. [1 ,2 ]
Kirpichnikov, Mikhail P. [1 ,2 ]
Trushina, Daria B. [3 ]
Gasparian, Marine E. [1 ]
机构
[1] RAS, Dept Bioengn, Inst Bioorgan Chem, Moscow, Russia
[2] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia
[3] Russian Acad Sci, Dept Xray & Synchrotron Res, AV Shubnikov Inst Crystallog Fed Sci Res Ctr Crys, Moscow, Russia
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金
俄罗斯基础研究基金会; 俄罗斯科学基金会;
关键词
DR5; DR4; TRAIL; receptor endocytosis; receptor recycling; membrane traffic; brefeldin A; SURFACE EXPRESSION; APOPTOSIS; RESISTANCE; CLATHRIN; NUCLEAR; INTERNALIZATION; LOCALIZATION; TRAFFICKING; APO2L/TRAIL; SELECTIVITY;
D O I
10.3389/fcell.2021.733688
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor necrosis factor-associated ligand inducing apoptosis (TRAIL) induces apoptosis through the death receptors (DRs) 4 and 5 expressed on the cell surface. Upon ligand stimulation, death receptors are rapidly internalized through clathrin-dependent and -independent mechanisms. However, there have been conflicting data on the role of death receptor endocytosis in apoptotic TRAIL signaling and possible cell type-specific differences in TRAIL signaling have been proposed. Here we have compared the kinetics of TRAIL-mediated internalization and subsequent recycling of DR4 and DR5 in resistant (HT-29 and A549) and sensitive (HCT116 and Jurkat) tumor cell lines of various origin. TRAIL stimulated the internalization of both receptors in a concentration-dependent manner with similar kinetics in sensitive and resistant cell lines without affecting the steady-state expression of DR4 and DR5 in cell lysates. Using the receptor-selective TRAIL variant DR5-B, we have shown that DR5 is internalized independently of DR4 receptor. After internalization and elimination of TRAIL from culture medium, the receptors slowly return to the plasma membrane. Within 4 h in resistant or 6 h in sensitive cells, the surface expression of receptors was completely restored. Recovery of receptors occurred both from newly synthesized molecules or from trans-Golgi network, as cycloheximide and brefeldin A inhibited this process. These agents also suppressed the expression of cell surface receptors in a time- and concentration-dependent manner, indicating that DRs undergo constitutive endocytosis. Inhibition of receptor endocytosis by sucrose led to sensitization of resistant cells to TRAIL and to an increase in its cytotoxic activity against sensitive cells. Our results confirm the universal nature of TRAIL-induced death receptor endocytosis, thus cell sensitivity to TRAIL can be associated with post-endocytic events.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL (vol 9, 733688, 2021)
    Artykov, Artem A.
    Yagolovich, Anne V.
    Dolgikh, Dmitry A.
    Kirpichnikov, Mikhail P.
    Trushina, Daria B.
    Gasparian, Marine E.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [2] Expression of TRAIL and the death receptors DR4 and DR5 correlates with progression of degeneration in human intervertebral disks
    Bertram, Helge
    Nerlich, Andreas
    Omlor, Georg
    Geiger, Florian
    Zimmermann, Gerald
    Fellenberg, Joerg
    MODERN PATHOLOGY, 2009, 22 (07) : 895 - 905
  • [3] Comparative binding to DR4 and DR5 receptors of TRAIL and BNNTs/PAHE/mPEG-DSPE/TRAIL nanoparticles
    Guillaume, Yves Claude
    Andre, Claire
    JOURNAL OF MOLECULAR RECOGNITION, 2017, 30 (07)
  • [4] Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells
    Ouyang, Wen
    Yang, Chunxu
    Liu, Yu
    Xiong, Jie
    Zhang, Junhong
    Zhong, Yahua
    Zhang, Gong
    Zhou, Fuxiang
    Zhou, Yunfeng
    Xie, Conghua
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (06) : 1577 - 1586
  • [5] Membrane expression of the death ligand trail receptors DR4 and DR5 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer
    Gottwald, L.
    Szwalski, J.
    Piekarski, J.
    Pasz-Walczak, G.
    Kubiak, R.
    Spych, M.
    Suzin, J.
    Tylinski, W.
    Sek, P.
    Jeziorski, A.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (05) : 512 - 518
  • [6] TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
    Lemke, Johannes
    Noack, Andreas
    Adam, Dieter
    Tchikov, Vladimir
    Bertsch, Uwe
    Roeder, Christian
    Schuetze, Stefan
    Wajant, Harald
    Kalthoff, Holger
    Trauzold, Anna
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (07): : 729 - 740
  • [7] TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
    Johannes Lemke
    Andreas Noack
    Dieter Adam
    Vladimir Tchikov
    Uwe Bertsch
    Christian Röder
    Stefan Schütze
    Harald Wajant
    Holger Kalthoff
    Anna Trauzold
    Journal of Molecular Medicine, 2010, 88 : 729 - 740
  • [8] Myeloid Differentiation Increases Resistance of Leukemic Cells to TRAIL-Induced Death by Reducing the Expression of DR4 and DR5 Receptors
    Lomovskaya, Ya, V
    Kobyakova, M., I
    Senotov, A. S.
    Fadeeva, I. S.
    Lomovsky, A., I
    Krasnov, K. S.
    Shtatnova, D. Yu
    Akatov, V. S.
    Fadeev, R. S.
    BIOLOGICHESKIE MEMBRANY, 2022, 39 (06): : 457 - 473
  • [9] Myeloid Differentiation Increases Resistance of Leukemic Cells to TRAIL-Induced Death by Reducing the Expression of DR4 and DR5 Receptors
    Lomovskaya, Ya. V.
    Kobyakova, M. I.
    Senotov, A. S.
    Fadeeva, I. S.
    Lomovsky, A. I.
    Krasnov, K. S.
    Shtatnova, D. Yu.
    Akatov, V. S.
    Fadeev, R. S.
    BIOCHEMISTRY MOSCOW SUPPLEMENT SERIES A-MEMBRANE AND CELL BIOLOGY, 2023, 17 (01) : 43 - 57
  • [10] Myeloid Differentiation Increases Resistance of Leukemic Cells to TRAIL-Induced Death by Reducing the Expression of DR4 and DR5 Receptors
    Ya. V. Lomovskaya
    M. I. Kobyakova
    A. S. Senotov
    I. S. Fadeeva
    A. I. Lomovsky
    K. S. Krasnov
    D. Yu. Shtatnova
    V. S. Akatov
    R. S. Fadeev
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2023, 17 : 43 - 57